戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y counteracted acute lung eosinophilia in an experimental animal model.
2 anges in differential renal blood flow in an experimental animal model.
3 ), using the conventional Fischer rat as the experimental animal model.
4  severity of aortic regurgitation (AR) in an experimental animal model.
5 ing microembolization to migraine aura in an experimental animal model.
6  iPFK-2 expression decreases tumor growth in experimental animal models.
7 sial temporal lobe epilepsy in humans and in experimental animal models.
8 s against many carcinogen-induced cancers in experimental animal models.
9 e less virulent than the wild-type strain in experimental animal models.
10  due in large part to the dearth of relevant experimental animal models.
11  inflammation in both human hypertension and experimental animal models.
12 s an important role in insulin resistance in experimental animal models.
13 ing the early stages of infection in several experimental animal models.
14 ponses have destroyed growing tumor cells in experimental animal models.
15  infection have been hindered by the lack of experimental animal models.
16 orodibenzo-p-dioxin and related compounds in experimental animal models.
17  inflammation in both human hypertension and experimental animal models.
18  is rare in animals and poorly reproduced in experimental animal models.
19 dance with several studies done in different experimental animal models.
20 is infection in both humans and unvaccinated experimental animal models.
21 s of CD4(+) regulatory T cells in humans and experimental animal models.
22 iding effective reduction of tumor burden in experimental animal models.
23 nset is limited by the lack of adjuvant-free experimental animal models.
24 ber D (NKG2D) mediates antitumor immunity in experimental animal models.
25  been developed for use in the clinic and in experimental animal models.
26 echanisms greater than that anticipated from experimental animal models.
27 mple of latent viral infection in humans and experimental animal models.
28 regs) to achieve this have been promising in experimental animal models.
29 brain injury and adversely affect outcome in experimental animal models.
30  has been hindered by a paucity of tractable experimental animal models.
31 d DC, and from analyses of their function in experimental animal models.
32 en studied extensively both in humans and in experimental animal models.
33 ions have also been identified in humans and experimental animal models.
34 ment and its disruption in human infants and experimental animal models.
35 tal programming can be modeled in a range of experimental animal models.
36 genetic mutations, and the complexity of the experimental animal models.
37 erum and many extraintestinal tissues in all experimental animal models.
38                                Thus, in this experimental animal model, a high-titer vaccine-induced
39                                           In experimental animal models, administration of talactofer
40 ivities of the superantigens, and protect an experimental animal model against shock.
41 ting transmission of Borrelia burgdorferi in experimental animal models and are now being tested in h
42 tional abnormalities previously described in experimental animal models and can at least partially ac
43           Analysis of these gene products in experimental animal models and cell systems has led to a
44                                              Experimental animal models and epidemiological data indi
45 ng in pain conditions.SIGNIFICANCE STATEMENT Experimental animal models and human psychophysical stud
46 ls in inflammation-induced bone loss in both experimental animal models and human rheumatoid arthriti
47 g to the changes observed with aging in both experimental animal models and humans.
48                                 Drawing from experimental animal models and observational human studi
49  stroke pathology has been underestimated in experimental animal models and this may have contributed
50 as been established by cell culture studies, experimental animal models, and clinical trials.
51 sceptibility, the necessity for adjuvants in experimental animal models, and the often paradoxical ef
52                                              Experimental animal models are indispensable to the fiel
53                                 However, new experimental animal models are now available that will a
54                        Studies in humans and experimental animal models are revealing the genetic and
55          Miniature pigs have been used as an experimental animal model, but they are still large and
56 circulation have been studied extensively in experimental animal models, but have failed to recapitul
57 e a human metabolic disease is induced in an experimental animal model by human hepatocyte transplant
58 malformations have been produced in multiple experimental animal models, by perturbing selected molec
59                    Sustained rapid pacing in experimental animal models can produce severe biventricu
60                                           In experimental animal models, chronic stress leads to neur
61              These ligands were tested in an experimental animal model containing tumors that express
62                         In human disease and experimental animal models, depressed Ca(2+) handling in
63 n the foundations of these approaches in new experimental animal models designed to test novel vaccin
64 section evaluates the use of agents given in experimental animal models during or after the onset of
65                       Clinical, in-vitro and experimental animal model evidence continues to mount in
66         To review the clinical, in-vitro and experimental animal model evidence for the pathogenicity
67               These studies describe a novel experimental animal model for examining the spontaneous
68                                 To create an experimental animal model for HD, transgenic mice were g
69 iniature pigs in the world and is used as an experimental animal model for life science research.
70 ammatory demyelinating disease, providing an experimental animal model for multiple sclerosis.
71 g disease in mice provides a highly relevant experimental animal model for multiple sclerosis.
72 in, DJ-1, PINK-1 and LRRK2) and studies from experimental animal models has provided crucial insights
73 sease, together with earlier studies and new experimental animal models, has provided important and n
74                                      Several experimental animal models have been developed to study
75                                   Studies in experimental animal models have demonstrated that chemok
76                 Several lines of evidence in experimental animal models have indicated the central ro
77                          Previous studies in experimental animal models have reported that administra
78 , explanted and biopsied human material, and experimental animal models, have demonstrated that liver
79 omparing brain function between patients and experimental animal models; however, the relationship be
80 ce from patients with heart failure and from experimental animal models implicates effectors of innat
81 mobilization of human progenitor cells in an experimental animal model in response to different treat
82 rtension-induced renal damage, we derived an experimental animal model in which two genetically diffe
83 alth benefits have been attributed to CLA in experimental animal models including actions to reduce c
84              These findings in humans and in experimental animal models indicate the presence of pote
85       Progressive renal injury in humans and experimental animal models is characterized by tubular a
86                        Due to the paucity of experimental animal models, little is known about how ho
87                              Importantly, in experimental animal models, low dietary potassium intake
88 h Mycobacterium tuberculosis were used in an experimental animal model mimicking active tuberculosis
89 ed neutrophil counts and MPO activity, in an experimental animal model of ALI induced by systemic end
90 ion carbohydrate antigens was studied in the experimental animal model of alpha1,3galactosyltransfera
91 ce induction to the alpha-gal epitope in the experimental animal model of alpha1,3galactosyltransfera
92                                 Although the experimental animal model of anterior chamber-associated
93                                           An experimental animal model of atopic dermatitis induced b
94                               A reproducible experimental animal model of fulminant hepatic failure (
95 to mediate collagen Ab-induced arthritis, an experimental animal model of immune complex-induced join
96 us CPs in modulating abscess formation in an experimental animal model of intraabdominal infection.
97       This hypothesis was tested in a unique experimental animal model of knockout mice for alpha1,3g
98                                           An experimental animal model of meningeal leukemia was deve
99 g gadolinium-labeled peptide, EP-1873, in an experimental animal model of plaque rupture and thrombos
100 ate it as a model of atopic dermatitis, this experimental animal model of pruritic inflammatory skin
101 tabolic acidosis and longer survival in this experimental animal model of septic shock.
102                                   Studies on experimental animal models of AF implicate a reduction i
103                                              Experimental animal models of AKI demonstrate that renal
104 iting cardiomyocyte apoptosis in 2 different experimental animal models of AMI.
105 he functions of natural killer (NK) cells in experimental animal models of atherosclerosis, it is not
106 pidemiologic studies, with some support from experimental animal models of atherosclerosis.
107 pidemiologic studies, with some support from experimental animal models of atherosclerosis.
108                       The most commonly used experimental animal models of CHIKV infection are mice a
109                                           In experimental animal models of chronic renal injury, such
110  pigs are capable of restoring euglycemia in experimental animal models of diabetes.
111  responses are present in cells derived from experimental animal models of diabetes.
112    Endogenous IL-1Ra is produced in numerous experimental animal models of disease as well as in huma
113  an arthritis susceptibility locus mapped in experimental animal models of disease has been used to i
114  and enhanced neuronal synchrony observed in experimental animal models of epilepsy characterizes hum
115 mechanism of apoptosis in conditions such as experimental animal models of glaucoma and optic nerve t
116 he sympathetic nervous system alterations in experimental animal models of hypertension.
117 and Rhizopus oryzae has been demonstrated in experimental animal models of infection.
118 ded evidence of such processes in humans and experimental animal models of insulin-resistant diabetes
119                Immunologic studies involving experimental animal models of L. tropica infection are v
120 linical studies of liver disease and certain experimental animal models of liver injury conspicuously
121 bly through the development of UV-responsive experimental animal models of melanoma.
122 vant to the induction of disease symptoms in experimental animal models of MG, since numerous reports
123 sthenia gravis (MG) in humans, as well as in experimental animal models of MG.
124 omosome 17q, homologous to a locus linked to experimental animal models of multiple sclerosis, has be
125 cularization and pulmonary hypertension in 2 experimental animal models of PAH in vivo Up-regulation
126                                           In experimental animal models of sepsis telavancin was show
127                                              Experimental animal models of type 1 diabetes mellitus (
128                                      Several experimental animal models of viral-induced neurodegener
129 dvanced, at least in part, due to the use of experimental animal models, particularly the model of ce
130          Genome-wide association studies and experimental animal models point at a central role of th
131                            Many fail because experimental animal models poorly predict human xenobiot
132 rally occurring plant estrogen in soy, in an experimental animal model previously reported to result
133 ition of FoxO1 function prevents diabetes in experimental animal models, providing impetus to identif
134 2)P beta-particle-emitting stents in various experimental animal models results in discordant effects
135 t and growth of carcinogen-induced tumors in experimental animal models, results from human studies a
136   This daring conclusion that is based on an experimental animal model should now be confirmed in hum
137                               Currently, few experimental animal models similar to humans are availab
138 is lacking, non-randomized observational and experimental animal model studies were used.
139                                              Experimental animal models, such as transgenic mice, hav
140              Furthermore, arguments based on experimental animal models suggest a critical role of th
141                     Recent studies involving experimental animal models suggest a role of the gut mic
142              Observational human studies and experimental animal models suggest that childhood exposu
143                        Previous results from experimental animal models suggest that post-TBI hypergl
144                                              Experimental animal models suggest that statins may fost
145                    Accumulated evidence from experimental animal models suggests that neuronal loss w
146                                              Experimental animal models support both the antibody and
147     Several published studies have used this experimental animal model system to demonstrate potentia
148  this review we focus on several widely used experimental animal model systems to highlight differenc
149 es in suppressing tumor cell regrowth in two experimental animal model systems.
150 alpha/beta) antagonist, both in vitro and in experimental animal model systems.
151     We review the recent clinical trials and experimental animal models that provide evidence in supp
152                                       In the experimental animal model, the hemodynamic, hematologic,
153                                           In experimental animal models, these compounds exhibited ex
154                                  As with all experimental animal models, they are flawed in one way o
155  known to inhibit DA-associated behaviors in experimental animal models through unknown mechanisms.
156 grating patient-based data with results from experimental animal models to gain deeper understanding
157                   In this review we focus on experimental animal models to identify quantitative trai
158  that prolongs the survival of allografts in experimental animal models, to potentiate the immunosupp
159             This prompted the development of experimental animal models using controlled maternal cal
160                                           An experimental animal model was used to assess the importa
161                           The development of experimental animal models was deemed essential for the
162                                        In an experimental animal model, we show that in vitro knockdo
163  mechanisms underlying these events using an experimental animal model, we show that inflammation may
164  of the present study was to determine in an experimental animal model whether CD8 T cells in pig xen
165 cilitates studies in platelets obtained from experimental animal models without the need of special d

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top